Abstract
Despite significant advances in the treatment of ischemic stroke, which were achieved due to the implementation of the program to combat stroke, the mortality and disability rates in this pathology continue to remain high. The identification of biochemical markers of the unfavorable clinical course of cerebral infarction is quite urgent, since it can be a useful addition to the optimization of predicting the outcomes of acute cerebrovascular catastrophe and the effectiveness of thrombolytic therapy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
